In the wake of the 2024 U.S. elections, stakeholders in the life sciences and health care industry are intensely focused on the policy ...

UNC Health and Duke Health formed a joint venture to build a 500-bed, free-standing children's hospital in the Piedmont, ...

Pfizer stock bounded off its 50-day line on Monday after avoiding a battle with activist investor Starboard Value — for ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Nearly two-thirds of Americans will have access to the virtual mental health provider’s services as it adds insurer partners, CEO Dr. Jon Cohen said.

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Charting, Price Performance, News & Related Contracts.

With key officials yet to be confirmed at the U.S. Department of Health and Human Services, the acting secretary imposed an immediate pause throughout the department on publicly issuing any document ...